Premium
HCC risk reduction with oral nucleos(t)ide analogues in patients with chronic hepatitis B: Not perfect, not good enough
Author(s) -
Yip Terry CheukFung,
Wong Grace LaiHung
Publication year - 2020
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.15249
Subject(s) - medicine , entecavir , hepatocellular carcinoma , tenofovir alafenamide , tenofovir , hepatology , cirrhosis , gastroenterology , hepatitis b virus , incidence (geometry) , chronic hepatitis , hepatitis b , oncology , virus , immunology , viral load , physics , human immunodeficiency virus (hiv) , antiretroviral therapy , lamivudine , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom